Article Details

AstraZeneca, Daiichi Sankyo's Enhertu recommended for approval in EU | Markets Insider

Retrieved on: 2025-02-28 14:37:34

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, Daiichi Sankyo's Enhertu recommended for approval in EU | Markets Insider. View article details on hiswai:

Excerpt

AstraZeneca (AZN) and Daiichi Sankyo's (DSNKY) trastuzumab deruxtecan has been recommended for approval in the European Union as a monotherapy f.

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up